Kadvilmet 50/500
This medication combines Vildagliptin and Metformin to manage Type 2 Diabetes Mellitus, aiming to improve glycemic control and prevent complications.
- The description claims the dual mechanism enhances insulin secretion and reduces glucose production.
- The description claims improved glycemic control and prevention of kidney damage, nerve problems, and heart diseases.
- The description claims potential support for weight management.
- Side effects include nausea, vomiting, stomach discomfort, headache, or dizziness.
Variants (1)
- Default Title — 90.00 INR — In stock
AI Readiness
Good foundation, but some important product data is still missing.
80%